The dysesthesia side effect Approximately 12.5% of participants on the highest dose of retatrutide experienced dysesthesia, or abnormal skin sensations, including a burning, tingling or pins and needles sensation
Read More: Could Fat-Trapping Boba Pearls Replace Weight Loss Medications Like GLP-1 Agonists
[DOI] [PMC free article] [PubMed] [Google Scholar] 85.Yoshida M., Satoh A., Lin J.B., Mills K.F., Sasaki Y., Rensing N., Wong M., Apte R.S., Imai S.I
Lilly designed TRIUMPH-1 to produce a number that can be placed directly next to those benchmarks on a regulatory label
This has the possibility of setting up a two-tier system whereby people who cant afford the more expensive drugs are only able to use drugs with less strong evidence of benefit, Krumholz said
This is attributed to GLP-1 receptor activity in the hypothalamus and brainstem, which modulates satiety signalling